---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-23-054632"
form_type: "8-K"
ticker: "IRD"
cik: "0001228627"
company_name: "Opus Genetics, Inc."
filed_at: "2023-11-27T23:59:59+00:00"
generated_at: "2026-06-07T21:21:10.521725+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Ocuphire Pharma appoints Joseph Schachle COO; $400K salary, 300K option grant

## Summary
- Joseph Schachle appointed COO effective Nov 27, 2023; previously COO of Opus Genetics.
- Base salary $400K, target annual bonus 45% of base, 300K stock option grant.
- Stock option vests 25% on 1-year anniversary, remaining monthly over 36 months.
- Appointment part of strategic initiative to advance lead retina asset APX3330 into registrational studies.
- Severance: 9 months salary continuation plus COBRA reimbursement if terminated without cause or for good reason.

## SEC filing metadata
- accession: 0001140361-23-054632
- form_type: 8-K
- ticker: IRD
- cik: 0001228627
- company_name: Opus Genetics, Inc.
- filed_at: 2023-11-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1228627/000114036123054632/0001140361-23-054632-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1228627/000114036123054632/ef20015189_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-23-054632
- JSON: https://secwatch.observer/filing/0001140361-23-054632.json
- Plain text: https://secwatch.observer/filing/0001140361-23-054632.txt

## Key facts
- Executive change
  Joseph Schachle was appointed as Chief Operating Officer at Opus Genetics, Inc..
  - Action: appointed
  - Role: Chief Operating Officer
  source text: On November 22, 2023, the Board of Directors (the “Board”) of Ocuphire Pharma, Inc. (the “Company”) appointed Joseph Schachle, age 58, as the Company’s Chief Operating Officer, effective as of November 27, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1228627/000114036123054632/0001140361-23-054632-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.